Dendritic cells loaded with HeLa-derived exosomes simulate an antitumor immune response

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Dendritic cells (DCs) are crucial antigen-presenting cells in initiating immune responses.
• Exosomes are small extracellular vesicles involved in intercellular communication.
• Cervical cancer remains a significant global health challenge, necessitating novel therapeutic strategies.

Purpose of the Study:

• To investigate the impact of exosome-loaded dendritic cells on cytotoxic T-lymphocyte (CTL) responses.
• To evaluate the cytotoxic effects of these enhanced CTL responses against HeLa cervical cancer cells.
• To explore a potential immunotherapy approach for cervical cancer.

Main Methods:

• Isolation of exosomes (HeLa-exo) from HeLa cells using ultrafiltration and sucrose density gradient ultracentrifugation.
• Characterization of HeLa-exo morphology (TEM) and CD63 expression (Western Blot).
• Induction and phenotypic characterization (flow cytometry) of monocyte-derived DCs, followed by loading with HeLa-exo. MTT assays and cytotoxicity assays were performed.

Main Results:

• HeLa-exo displayed characteristic cup-shaped morphology (30-100 nm) and expressed CD63.
• Successful induction of monocyte-derived DCs was confirmed by CD1a expression and typical morphology.
• DCs loaded with HeLa-exo significantly enhanced CTL proliferation and cytotoxic activity compared to controls (P<0.05).

Conclusions:

• Dendritic cells loaded with HeLa-derived exosomes effectively stimulate T-cell proliferation.
• This approach induces robust CTL responses capable of inhibiting cervical cancer cell growth in vitro.
• Exosome-modified DCs represent a promising strategy for developing novel cervical cancer immunotherapies.